Promoter Vividhmargi Investments Private Limited increased its stake in Themis Medicare Limited from 15.77% to 26.52% by acquiring 9,901,040 shares worth ₹69.83 Cr on March 24, 2026. This inter-se promoter transfer occurred due to an amalgamation scheme.
A pharmaceutical manufacturer established in 1969, Themis Medicare produces formulations and active pharmaceutical ingredients for domestic and international markets. The company operates across the full spectrum of drug development, from API synthesis to finished dosage forms, serving hospitals, clinics, and retail pharmacies. Its vertically integrated operations enable control over quality and supply chain efficiency while maintaining competitive positioning in the Indian pharmaceutical sector.
Get the next move the moment it happens.
Follow the investors and Themis Medicare Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
